Fig. 2: The change of MRD status after the first consolidation chemotherapy and clinical outcomes according to MRD status after the first and the second consolidation chemotherapy. | Blood Cancer Journal

Fig. 2: The change of MRD status after the first consolidation chemotherapy and clinical outcomes according to MRD status after the first and the second consolidation chemotherapy.

From: MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study

Fig. 2

(A) Description and transition of MRD status after the first consolidation chemotherapy. Probabilities of clinical outcomes for patients with MRDcon1 negativity (B) and with MRDcon1 positivity (C) receiving allo-HSCT after the first consolidation directly; Probabilities of clinical outcomes for patients with MRDcon2 negativity (D) and with MRDcon2 positivity (E) receiving allo-HSCT after the second consolidation directly.

Back to article page